Contract facts
FederalPLUVICTO is a federal award for 250-Network Contract Office 10 (36C250) held by Novartis Pharmaceuticals Corp. Estimated value —. Related solicitation NONE.
Incumbent footprint
Public recordNovartis Pharmaceuticals Corp — $23.5M obligated across 59 awards (firm-wide, all agencies) · lead buyer Department of Veterans Affairs (VA).
Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract 36C25026A0001?
36C25026A0001 (Pluvicto) is a 250-Network Contract Office 10 (36C250) award with an estimated value of —, currently held by Novartis Pharmaceuticals Corp. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
What is 36C250-26-A-0001?
36C250-26-A-0001 is the dashed form of PIID 36C25026A0001 (Pluvicto), held by Novartis Pharmaceuticals Corp. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.
Which office awarded 36C25026A0001?
250-Network Contract Office 10 (36C250) awarded 36C25026A0001 to Novartis Pharmaceuticals Corp.
Who is the incumbent on 36C25026A0001?
Novartis Pharmaceuticals Corp is the incumbent with $23.5M across 59 related awards in SCOUT’s public footprint.
When does Novartis Pharmaceuticals Corp’s 36C25026A0001 come up for recompete?
SCOUT tracks a period-of-performance end of an unstated date. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.